vs
STANDARD BIOTOOLS INC.（LAB）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$25.9M vs $19.6M），REDWOOD TRUST INC净利率更高（77.2% vs -177.4%，领先254.6%），REDWOOD TRUST INC同比增速更快（-6.1% vs -11.5%），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -41.0%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
LAB vs RWT — 直观对比
营收规模更大
RWT
是对方的1.3倍
$19.6M
营收增速更快
RWT
高出5.4%
-11.5%
净利率更高
RWT
高出254.6%
-177.4%
两年增速更快
LAB
近两年复合增速
-41.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $25.9M |
| 净利润 | $-34.7M | $20.0M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | — |
| 净利率 | -177.4% | 77.2% |
| 营收同比 | -11.5% | -6.1% |
| 净利润同比 | -28.8% | 402.6% |
| 每股收益（稀释后） | $-0.09 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABRWT
| Q4 25 | — | $25.9M | ||
| Q3 25 | $19.6M | $15.0M | ||
| Q2 25 | $21.8M | $13.8M | ||
| Q1 25 | $40.8M | $27.9M | ||
| Q4 24 | — | $27.6M | ||
| Q3 24 | $22.1M | $25.5M | ||
| Q2 24 | $22.5M | $67.4M | ||
| Q1 24 | $45.5M | $74.5M |
净利润LABRWT
| Q4 25 | — | $20.0M | ||
| Q3 25 | $-34.7M | $-7.7M | ||
| Q2 25 | $-33.5M | $-98.5M | ||
| Q1 25 | $-26.0M | $16.1M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $-26.9M | $14.8M | ||
| Q2 24 | $-45.7M | $15.5M | ||
| Q1 24 | $-32.2M | $30.3M |
毛利率LABRWT
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABRWT
| Q4 25 | — | — | ||
| Q3 25 | -168.5% | -9.0% | ||
| Q2 25 | -118.1% | -679.0% | ||
| Q1 25 | -80.8% | 80.2% | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | -120.9% | 86.1% | ||
| Q2 24 | -134.5% | 30.3% | ||
| Q1 24 | -132.2% | 41.3% |
净利率LABRWT
| Q4 25 | — | 77.2% | ||
| Q3 25 | -177.4% | -51.4% | ||
| Q2 25 | -153.7% | -712.0% | ||
| Q1 25 | -63.8% | 57.8% | ||
| Q4 24 | — | -24.0% | ||
| Q3 24 | -122.0% | 58.1% | ||
| Q2 24 | -203.3% | 23.0% | ||
| Q1 24 | -70.6% | 40.6% |
每股收益（稀释后）LABRWT
| Q4 25 | — | $0.11 | ||
| Q3 25 | $-0.09 | $-0.08 | ||
| Q2 25 | $-0.09 | $-0.76 | ||
| Q1 25 | $-0.07 | $0.10 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $-0.07 | $0.09 | ||
| Q2 24 | $-0.12 | $0.10 | ||
| Q1 24 | $-0.27 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $982.6M |
| 总资产 | $539.6M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABRWT
| Q4 25 | — | $255.7M | ||
| Q3 25 | $129.4M | $226.3M | ||
| Q2 25 | $158.6M | $302.0M | ||
| Q1 25 | $150.9M | $259.9M | ||
| Q4 24 | — | $245.2M | ||
| Q3 24 | $210.6M | $253.7M | ||
| Q2 24 | $269.8M | $275.6M | ||
| Q1 24 | $287.1M | $275.4M |
总债务LABRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | $1.7B |
股东权益LABRWT
| Q4 25 | — | $982.6M | ||
| Q3 25 | $399.7M | $999.0M | ||
| Q2 25 | $424.5M | $1.1B | ||
| Q1 25 | $454.6M | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $489.3M | $1.2B | ||
| Q2 24 | $510.3M | $1.2B | ||
| Q1 24 | $577.3M | $1.2B |
总资产LABRWT
| Q4 25 | — | $23.7B | ||
| Q3 25 | $539.6M | $22.6B | ||
| Q2 25 | $557.0M | $21.3B | ||
| Q1 25 | $579.6M | $19.9B | ||
| Q4 24 | — | $18.3B | ||
| Q3 24 | $681.5M | $18.4B | ||
| Q2 24 | $708.7M | $16.5B | ||
| Q1 24 | $777.7M | $15.1B |
负债/权益比LABRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABRWT
| Q4 25 | — | $-10.1B | ||
| Q3 25 | $-22.2M | $-2.7B | ||
| Q2 25 | $-20.7M | $-2.1B | ||
| Q1 25 | $-30.3M | $-2.0B | ||
| Q4 24 | — | $-5.9B | ||
| Q3 24 | $-27.9M | $-2.1B | ||
| Q2 24 | $-39.0M | $-2.0B | ||
| Q1 24 | $-62.5M | $-954.2M |
自由现金流LABRWT
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率LABRWT
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度LABRWT
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
现金转化率LABRWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
RWT
暂无分部数据
